Scarica l'app Stockscreener
84.46
1.60%
1.33
Dopo l'orario di chiusura:
84.50
0.04
+0.05%
Oruka Therapeutics Inc Borsa (ORKA) Ultime notizie
ORKA Stock Is Soaring After Psoriasis Trial Results — Here's Why BTIG Hiked Its Price Target By 94% - Stocktwits
UBS Maintains Oruka Therapeutics(ORKA.US) With Buy Rating, Maintains Target Price $130 - Moomoo
Oruka Therapeutics (ORKA) Sees 8.1% Decline - GuruFocus
Oruka Therapeutics Insider Sold Shares Worth $472,079, According to a Recent SEC Filing - marketscreener.com
Oruka Therapeutics Shares Drop After Hours After Fairmount Unloads 3.55 Million Shares - Benzinga
Form 13D/A ORUKA THERAPEUTICS For: 1 July By Investing.com - Investing.com India
Fairmount Healthcare Fund II sells $300m Oruka Therapeutics stock By Investing.com - Investing.com Australia
Form 144 | Oruka Therapeutics(ORKA.US) Insider Proposes to Sell 300.01 Million in Common Stocks - Moomoo
Insider Sell: Laura Sandler Sells 5,000 Shares of Oruka Therapeu - GuruFocus
Form 144 Oruka Therapeutics For: 1 July By Investing.com - Investing.com Nigeria
Fairmount Healthcare Fund II sells $300m Oruka Therapeutics stock - Investing.com
Form 144 Oruka Therapeutics For: 1 July - Investing.com UK
Why Oruka Therapeutics (ORKA) Is Up 13.6% After Russell Index Reclassification Into Growth Benchmarks - simplywall.st
Oruka Therapeutics COO Laura Sandler sells $472,078 in stock - Investing.com
Oruka Therapeutics COO Laura Sandler sells $472,078 in stock By Investing.com - Investing.com South Africa
Form 4 Oruka Therapeutics Inc For: 1 July By Investing.com - Investing.com India
Form 4 Oruka Therapeutics Inc For: 1 July - Investing.com UK
Price to book forward of Oruka Therapeutics, Inc. – NASDAQ:ORKA - TradingView
H.C. Wainwright Keeps Buy Rating on Oruka (ORKA) After Apogee Acquisition News - Insider Monkey
Oruka Therapeutics H2 ORKA-001 Data Could Further De-Risk Lead Program, UBS Says - marketscreener.com
UBS raises Oruka Therapeutics stock price target to $130 on efficacy data outlook - Investing.com Australia
Price to book forward of Oruka Therapeutics, Inc. – XETR:HQ1 - TradingView
Top 10 Hot Stocks with the Highest Upside Potential - Insider Monkey
Oruka Therapeutics stock hits 52-week high at 91.2 USD By Investing.com - Investing.com Australia
Oruka Therapeutics, Inc.(NasdaqGM: ORKA) dropped from Russell 3000E Index - marketscreener.com
Oruka Therapeutics stock hits 52-week high at 91.2 USD - Investing.com
Oruka Therapeutics, Inc.(NasdaqGM: ORKA) added to Russell 2000 Growth Benchmark - marketscreener.com
Oruka Therapeutics, Inc.(NasdaqGM:ORKA) dropped from Russell Small Cap Comp Value Benchmark - marketscreener.com
Oruka Therapeutics, Inc.(NasdaqGM: ORKA) added to Russell 3000E Growth Benchmark - marketscreener.com
Stifel Maintains Oruka Therapeutics(ORKA.US) With Buy Rating, Maintains Target Price $150 - Moomoo
Oruka Therapeutics, Inc.(NasdaqGM: ORKA) dropped from Russell Microcap Index - marketscreener.com
Oruka Therapeutics, Inc.(NasdaqGM: ORKA) dropped from Russell 3000 Value Benchmark - marketscreener.com
Oruka Therapeutics, Inc.(NasdaqGM: ORKA) dropped from Russell 2500 Value Benchmark - marketscreener.com
Oruka Therapeutics, Inc.(NasdaqGM:ORKA) dropped from Russell Microcap Value Benchmark Index - marketscreener.com
Enterprise value to EBITDA forward of Oruka Therapeutics, Inc. – NASDAQ:ORKA - TradingView
Enterprise value to EBITDA forward of Oruka Therapeutics, Inc. – TRADEGATE:HQ1 - TradingView
Oruka Therapeutics, Inc.(NasdaqGM: ORKA) added to Russell 3000 Growth Benchmark - marketscreener.com
Oruka Stock Is Now Up Nearly 700%. Here's What a $687,000 Insider Sale Could Mean - Yahoo Finance
Oruka Stock Is Now Up Nearly 700%. Here's What a $687,000 Insider Sale Could Mean - The Motley Fool
Oruka Therapeutics, Inc. Actuals & Estimates (DUS:HQ1) - TradingView
Enterprise value to revenue forward of Oruka Therapeutics, Inc. – NASDAQ:ORKA - TradingView
Price to earnings forward of Oruka Therapeutics, Inc. – NASDAQ:ORKA - TradingView
ORKA Forecast — Price Target — Prediction for 2027 - TradingView
Enterprise value to EBIT forward of Oruka Therapeutics, Inc. – NASDAQ:ORKA - TradingView
HQ1 Forecast — Price Target — Prediction for 2027 - TradingView
Price to earnings forward of Oruka Therapeutics, Inc. – TRADEGATE:HQ1 - TradingView
Oruka Therapeutics' Head of Finance Sold Over 10,000 Company Shares. What Does That Mean for Investors? - AOL.com
Price to book forward of Oruka Therapeutics, Inc. – TRADEGATE:HQ1 - TradingView
Price to sales forward of Oruka Therapeutics, Inc. – TRADEGATE:HQ1 - TradingView
Oruka Therapeutics, Inc. (NASDAQ: ORKA) Share Price, ORKA Stock News, ORKA Share Price & Updates - Kalkine
Oruka Therapeutics (ORKA) Is Up 5.1% After Positive Trial Update And Insider Share SalesWhat's Changed - Sahm
H.C. Wainwright Maintains Oruka Therapeutics(ORKA.US) With Buy Rating, Maintains Target Price $120 - Moomoo
Oruka Therapeutics Inc (ORKA) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
1.18%
2.48%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):